Benefits of Microcor in Ambulatory Decompensated Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 265 participants.

Also called NCT04096040

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 265 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04096040
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, France, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04096040. Allocation not applicable; no masking; primary purpose diagnostic. Start 2019-11-01 (actual); primary completion 2023-06-30 (actual). Results posted on 2024-10-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Benefits of Microcor in Ambulatory Decompensated Heart Failure
Acronym
BMAD-TX
Condition
Heart Failure
Intervention (Device)
μCor
Lead sponsor
Zoll Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct04096040
Content hash
38358277c8d1e34b73ceab91a750268e9ce7b3714e23086dded8f39ed805e058